Related references
Note: Only part of the references are listed.Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study
A. Tran-Duy et al.
JOURNAL OF INTERNAL MEDICINE (2019)
Proton pump inhibitors therapy and the risk of pneumonia: a systematic review and meta-analysis of randomized controlled trials and observational studies
Chih-Hung Wang et al.
EXPERT OPINION ON DRUG SAFETY (2019)
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin
Paul Moayyedi et al.
GASTROENTEROLOGY (2019)
Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study
Yan Xie et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Proton pump inhibitors and 180-day mortality in the elderly after Clostridium difficile treatment
Evan Stuart Bradley et al.
GUT PATHOGENS (2019)
Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis
Silvia Nardelli et al.
HEPATOLOGY (2019)
Patients' Perceptions of Proton Pump Inhibitor Risks and Attempts at Discontinuation: A National Survey
Jacob E. Kurlander et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Proton pump inhibitor-induced hypomagnesemia complicated with serious cardiac arrhythmias
Steven G. Chrysant
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2019)
Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study
Ka Shing Cheung et al.
GUT (2018)
Treatment with proton pump inhibitors is associated with increased mortality in patients with pyogenic liver abscess
D. Bettinger et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
The Risk of Community-Acquired Enteric Infection in Proton Pump Inhibitor Therapy: Systematic Review and Meta-analysis
Radwan A. Hafiz et al.
ANNALS OF PHARMACOTHERAPY (2018)
Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency
David Y. Graham et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
L. Clifford McDonald et al.
CLINICAL INFECTIOUS DISEASES (2018)
The association of proton pump inhibitors and chronic kidney disease: cause or confounding?
Tingting Li et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2018)
No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014)
Suzanne N. Landi et al.
GASTROENTEROLOGY (2018)
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
JOURNAL OF HEPATOLOGY (2018)
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
Janusz A. Z. Jankowski et al.
LANCET (2018)
A safety review of proton pump inhibitors to treat acid-related digestive diseases
Edoardo Savarino et al.
EXPERT OPINION ON DRUG SAFETY (2018)
The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal
Vincenzo Savarino et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2017)
Complications of Proton Pump Inhibitor Therapy
Michael F. Vaezi et al.
GASTROENTEROLOGY (2017)
The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association
Daniel E. Freedberg et al.
GASTROENTEROLOGY (2017)
Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans
Yan Xie et al.
BMJ OPEN (2017)
Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults
Alfredo J. Lucendo et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2017)
Proton pump inhibitors affect the gut microbiome
Floris Imhann et al.
GUT (2016)
Long-Term PPI Use: Balancing Potential Harms and Documented Benefits
Loren Laine et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
We Are Using Too Many PPIs, and We Need to Stop: A European Perspective
Angel Lanas
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
National trends in prescription drug expenditures and projections for 2016
Glen T. Schumock et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2016)
Efficacy of Proton Pump Inhibitor Drugs for Inducing Clinical and Histologic Remission in Patients With Symptomatic Esophageal Eosinophilia: A Systematic Review and Meta-Analysis
Alfredo J. Lucendo et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Proton pump inhibitor therapy and its association with spontaneous bacterial peritonitis incidence and mortality: A meta-analysis
Ting Yu et al.
DIGESTIVE AND LIVER DISEASE (2016)
Are proton pump inhibitors really so dangerous?
Vincenzo Savarino et al.
DIGESTIVE AND LIVER DISEASE (2016)
Gastroduodenal Disorders
Vincenzo Stanghellini et al.
GASTROENTEROLOGY (2016)
Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD
Yan Xie et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity
Alexandra Zhernakova et al.
SCIENCE (2016)
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
Benjamin Lazarus et al.
JAMA INTERNAL MEDICINE (2016)
Association of Proton Pump Inhibitors With Risk of Dementia A Pharmacoepidemiological Claims Data Analysis
Willy Gomm et al.
JAMA NEUROLOGY (2016)
Frequency and time to onset of community-acquired respiratory tract infections in patients receiving esomeprazole: a retrospective analysis of patient-level data inplacebo-controlled studies
L. Estborn et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study
Daniel E. Freedberg et al.
CLINICAL INFECTIOUS DISEASES (2015)
Recurrent Clostridium difficile infection is associated with increased mortality
M. A. Olsen et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Systematic review and meta-analysis of the possible association between pharmacological gastric acid suppression and spontaneous bacterial peritonitis
Muhammad Ali Khan et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis
H. B. Xu et al.
GENETICS AND MOLECULAR RESEARCH (2015)
The Morbidity, Mortality, and Costs Associated with Clostridium difficile Infection
Jennie H. Kwon et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2015)
Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: A multicenter prospective study
Ruben Terg et al.
JOURNAL OF HEPATOLOGY (2015)
16S Community Profiling Identifies Proton Pump Inhibitor Related Differences in Gastric, Lung, and Oropharyngeal Microflora
Rachel Rosen et al.
JOURNAL OF PEDIATRICS (2015)
Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries
Chen Mo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis
G. Dultz et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Risk of dementia in elderly patients with the use of proton pump inhibitors
Britta Haenisch et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2015)
Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis
Allison A. Lambert et al.
PLOS ONE (2015)
Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoea
Karl Weiss et al.
BMJ OPEN GASTROENTEROLOGY (2015)
Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study
Y. W. Min et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis
Kristian B. Filion et al.
GUT (2014)
Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients
Mette Krag et al.
INTENSIVE CARE MEDICINE (2014)
Mortality associated with proton pump inhibitors in cirrhotic patients with spontaneous bacterial peritonitis
Jee Hye Kwon et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Proton Pump Inhibitor Intake neither Predisposes to Spontaneous Bacterial Peritonitis or Other Infections nor Increases Mortality in Patients with Cirrhosis and Ascites
Mattias Mandorfer et al.
PLOS ONE (2014)
Acid Suppression Therapy Does Not Predispose to Clostridium difficile Infection: The Case of the Potential Bias
Lena Novack et al.
PLOS ONE (2014)
Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth
C. Jacobs et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease
Philip O. Katz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Use of proton pump inhibitors is associated with lower trabecular bone density in older individuals
Marcello Maggio et al.
BONE (2013)
Proton Pump Inhibitor Use and the Risk of Small Intestinal Bacterial Overgrowth: A Meta-analysis
Wai-Kit Lo et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Proton Pump Inhibitor and Histamine 2 Receptor Antagonist Use and Vitamin B12 Deficiency
Jameson R. Lam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
The Proton-Pump Inhibitor Lansoprazole Enhances Amyloid Beta Production
Nahuai Badiola et al.
PLOS ONE (2013)
Proton Pump Inhibitors and Risk of 1-Year Mortality and Rehospitalization in Older Patients Discharged From Acute Care Hospitals
Marcello Maggio et al.
JAMA INTERNAL MEDICINE (2013)
The Relationship Between Proton Pump Inhibitor Use and Longitudinal Change in Bone Mineral Density: A Population-Based From the Canadian Multicentre Osteoporosis Study (CaMos)
Laura E. Targownik et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care
D. Ahrens et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2012)
Risk of Death Associated With Use of PPIs in Three Cohorts of Institutionalized Older People in Finland
Mariko Teramura-Gronblad et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2012)
The risks of PPI therapy
Paul Moayyedi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
The changing face of hospitalisation due to gastrointestinal bleeding and perforation
A. Lanas et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection
C. Bavishi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Iatrogenic Gastric Acid Suppression and the Risk of Nosocomial Clostridium difficile Infection
Michael D. Howell et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract
Carlos Sostres et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2010)
Clopidogrel with or without Omeprazole in Coronary Artery Disease.
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel
Jolanta M. Siller-Matula et al.
AMERICAN HEART JOURNAL (2009)
Proton Pump Inhibitor Use and Enteric Infections
M. Sandra Dial
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Time Trends and Impact of Upper and Lower Gastrointestinal Bleeding and Perforation in Clinical Practice
Angel Lanas et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
David N. Juurlink et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
Acid-Suppressive Medication Use and the Risk for Hospital-Acquired Pneumonia
Shoshana J. Herzig et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals
W. P. J. Den Elzen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Inadequate use of proton-pump inhibitors in patients with liver cirrhosis
Evangelos Kalaitzakis et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2008)
Influence of gastric acid on susceptibility to infection with ingested bacterial pathogens
Sharon M. Tennant et al.
INFECTION AND IMMUNITY (2008)
Systematic review: proton pump inhibitor-associated acute interstitial nephritis
F. Sierra et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants
Angel Lanas et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Long-term proton pump inhibitor therapy and risk of hip fracture
Yu-Xiao Yang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Vitamin B12, folic acid, and the nervous system
Edward Reynolds
LANCET NEUROLOGY (2006)
Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients
Joel J. Heidelbaugh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease
S Dial et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Effects of proton pump inhibitors on calcium carbonate absorption in women: A randomized crossover trial
MB O'Connell et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs
RJF Laheij et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Stratifying the risk of NSAID-related upper gastrointestinal clinical events: Results of a double-blind outcomes study in patients with rheumatoid arthritis
L Laine et al.
GASTROENTEROLOGY (2002)
Share Paper
